Curadis GmbH
Records under this name other than the patents Curadis GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Curadis GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,610,292 | Uses for 4,17β-dihydroxyandrost-4-ene-3-one Lapsed on the fee record Ended Apr 4, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | USPTO record |
| US 9,138,477 | Uses for 4,17β-dihydroxyandrost-4-ene-3-one Lapsed on the fee record Ended Sep 22, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | USPTO record |
| US 9,114,163 | Medication against breast cancer and related diseases Lapsed on the fee record Ended Aug 25, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 25, 2023 | USPTO record |
| US 10,265,328 | C-19 steroids for specific therapeutic uses Lapsed on the fee record Ended Apr 23, 2023 · USPTO record | Lapsed on the fee record | Ended Apr 23, 2023 | USPTO record |
| US 8,278,291 | Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof Term ended Term ended Jul 28, 2020 · USPTO record | Term ended | Term ended Jul 28, 2020 | USPTO record |
| US 8,343,948 | Medicament for preventing and/or treating mammary carcinoma, containing a steroidal aromatase inhibitor Term ended Term ended May 5, 2020 · USPTO record | Term ended | Term ended May 5, 2020 | USPTO record |